Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Topotecan with Carboplatin and Paclitaxel in Ovarian Cancer
NCT00003732Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Sep 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topotecan in ovarian epithelial cancer, sponsored by Rigshospitalet. Started Sep 1998; status: completed.
02
Drugs
topotecan
03
Conditions
ovarian epithelial cancer
Beyond the preview
Go deeper on NCT00003732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003732.